Home/Filings/4/0001562180-19-005058
4//SEC Filing

ALLEN LEE F MD PhD 4

Accession 0001562180-19-005058

CIK 0001685071other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:21 PM ET

Size

5.0 KB

Accession

0001562180-19-005058

Insider Transaction Report

Form 4
Period: 2019-09-30
ALLEN LEE F MD PhD
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2019-09-30$28.00/sh978$27,3849,635 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.

Issuer

Dova Pharmaceuticals Inc.

CIK 0001685071

Entity typeother

Related Parties

1
  • filerCIK 0001408474

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:21 PM ET
Size
5.0 KB